Xanthomatosis, Cerebrotendinous clinical trials

The registry lists 23 studies for Xanthomatosis, Cerebrotendinous across more than 10 countries. 4 are recruiting or about to start. 12 of them are mainly about Xanthomatosis, Cerebrotendinous (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Xanthomatosis, Cerebrotendinous studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 8
Status unknown: 6
Recruiting: 3
Terminated: 2
Withdrawn: 2
Enrolling by invitation: 1

Phase

Phase 3: 3
Phase 1: 2
Phase 2: 1

Where

United States: 10
Turkey: 3
Israel: 2
Finland: 1
Germany: 1
Italy: 1

Who runs them

TRPHARM (3) · Children's Hospital of Philadelphia (2) · Alexandria University (1) · Leadiant Biosciences, Inc. (1) · National Center for Research Resources (NCRR) (1) · Sheba Medical Center (1) · University of Florida (1) · Postgraduate Institute of Dental Sciences Rohtak (1)

What is being tested here

Drugs under test in Xanthomatosis, Cerebrotendinous studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Chenodeoxycholic Acid	1	4
Zoledronic Acid	1	1
Lovastatin	0	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Nov 2026Early Check: Expanded Screening in Newborns · RTI International

Who these studies take

Of the 3 Xanthomatosis, Cerebrotendinous studies recruiting now, 2 (67%) set no upper age limit and 1 (33%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	1 (33%)	1 (33%)
18	3 (100%)	3 (100%)
30	3 (100%)	3 (100%)
40	3 (100%)	3 (100%)
50	2 (67%)	2 (67%)
65	2 (67%)	2 (67%)
75	2 (67%)	2 (67%)
85	2 (67%)	2 (67%)

Across all 23 studies, recruiting or not: 43% stop at 75 or younger and 39% at 65; 70% take children; 4% are for women only and 0% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 23 of 23. search them.